Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

191.40
+0.82000.43%
Post-market: 191.890.4900+0.26%19:59 EDT
Volume:4.85M
Turnover:926.93M
Market Cap:338.09B
PE:81.80
High:192.12
Open:189.00
Low:188.26
Close:190.58
Loading ...

Abbvie Inc - Verona Trial for Hr-Mds Did Not Meet Primary Endpoint

THOMSON REUTERS
·
16 Jun

Abbvie Inc - No New Safety Signals Observed in Verona Trial

THOMSON REUTERS
·
16 Jun

Bernstein Sticks to Its Hold Rating for AbbVie (ABBV)

TIPRANKS
·
13 Jun

Balanced Outlook for AbbVie: Hold Rating Amid Opportunities and Challenges

TIPRANKS
·
13 Jun

Senators Propose Ban on Drug Advertising to Consumers -- Update

Dow Jones
·
13 Jun

FDA Approves AbbVie's MAVYRET® for Expanded Use in Treating Acute Hepatitis C, Supporting Global Disease Elimination Goals

Reuters
·
12 Jun

U.S. FDA Approves Expanded Indication for Abbvie's Mavyret® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People With Acute Hepatitis C Virus

THOMSON REUTERS
·
12 Jun

Drug pricing reform talks with US government lack clarity, industry executives say

Reuters
·
11 Jun

Abbvie CEO on Drug Pricing Reform Says "Quite a Long Way to Go" in Terms of Reaching an Agreement

THOMSON REUTERS
·
10 Jun

Abbvie CEO Says Conversations With President Donald Trump on Drug Pricing Reform Have Been "Productive" - Goldman Sachs Conference

THOMSON REUTERS
·
10 Jun

Innoviva Inc. Announces FDA Acceptance of New Drug Application for Zoliflodacin, Paving Way for New Gonorrhea Treatment

Reuters
·
10 Jun

Bernstein Sticks to Their Hold Rating for AbbVie (ABBV)

TIPRANKS
·
10 Jun

Analysts Are Neutral on These Healthcare Stocks: AbbVie (ABBV), Bio-Techne (TECH)

TIPRANKS
·
10 Jun

Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector?

Dow Jones
·
07 Jun

AbbVie call volume above normal and directionally bullish

TIPRANKS
·
04 Jun

High Growth Tech Stocks To Watch In The US June 2025

Simply Wall St.
·
03 Jun

Kymera Stock Jumps. New Dermatitis Pill Could Challenge Regeneron Blockbuster. -- Barrons.com

Dow Jones
·
02 Jun

BUZZ-Xilio Therapeutics drops on equity raise plans

Reuters
·
02 Jun

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV) and Gilead Sciences (GILD)

TIPRANKS
·
02 Jun

Berenberg Adjusts Price Target on AbbVie to $170 From $195, Maintains Hold Rating

MT Newswires Live
·
30 May